Cyfip2 Network

Cyfip2 Network CYFIP2 Network is a nonprofit organization supporting families and research of CYFIP2 EIEE. Text CYFIP2 to 44321.

We’re proud to share that the CYFIP2 Network has officially submitted a request to add the gene CYFIP2 to Florida's Suns...
01/07/2026

We’re proud to share that the CYFIP2 Network has officially submitted a request to add the gene CYFIP2 to Florida's Sunshine Genetics Newborn Screening program, which officially kicks off in early 2026.
If approved, this would be a major step forward for families.

🧬 Why this matters:
Newborn screening can lead to earlier diagnosis, sometimes before symptoms even begin. For CYFIP2 families, this could mean: faster access to pediatric neurology and genetics care, earlier seizure monitoring and intervention, quicker connection to therapies and support services, less time spent searching for answers during critical early months, and stronger data to advance research and future treatments.

For too many families, the journey to a CYFIP2 diagnosis is long, confusing, and filled with uncertainty. Adding CYFIP2 to newborn screening has the potential to change that story... bringing clarity, support, and care sooner rather than later.

We’ll keep you updated as we move through the process!

Understanding Dysautonomia: Could this explain some of the symptoms seen in children with CYFIP2?This is a topic we bega...
12/31/2025

Understanding Dysautonomia: Could this explain some of the symptoms seen in children with CYFIP2?

This is a topic we began thinking about in a very personal way. Recently, we traveled home with Lucas to the far east end of Long Island, NY, right on the coast, where the wind is strong and cold. Every time we took Lucas outside, even briefly to get him into the car, he would suddenly vomit. There was no retching, no warning, and no other signs of distress. Despite being on Nexium for years, vomiting is one symptom we have never been able to fully explain, and we’ve long suspected it wasn’t truly coming from his stomach or reflux. Experiencing this has made us pause and ask a deeper question: could this be related to how his nervous system responds to environmental stress like cold and wind? That question led us to dysautonomia.

🧠 What is Dysautonomia?
Dysautonomia is an umbrella term used to describe dysfunction of the autonomic nervous system (ANS). The ANS controls many automatic body functions we don’t consciously think about, such as:

• Heart rate and blood pressure
• Breathing
• Digestion and gut motility
• Temperature regulation
• Sweating
• Bladder and bowel function

When this system doesn’t regulate properly, the body struggles to maintain balance, especially during stress, illness, or environmental changes like temperature shifts.

🔍 Why Does Dysautonomia Happen?
Dysautonomia can occur for many reasons, including:

• Genetic or neurodevelopmental conditions
• Brain injury or abnormal brain development
• Dysfunction in the brainstem or peripheral nerves
• Immune or inflammatory processes
• Mitochondrial or metabolic dysfunction
• Secondary effects of seizures or chronic neurological stress

In children with complex neurological disorders, dysautonomia is often secondary, meaning it arises as part of broader nervous system involvement rather than being a primary diagnosis.

⚠️ Common Symptoms
Symptoms can vary widely and may fluctuate day to day. Children may experience:

• Abnormal heart rate (too fast, too slow, or variable)
• Blood pressure instability
• Temperature instability (runs hot or cold, poor fever response)
• Excessive or absent sweating
• Chronic constipation, reflux, or feeding intolerance
• Nausea or vomiting (often without typical GI warning signs)
• Fatigue or low stamina
• Color changes (pale, flushed, mottled, or bluish hands/feet)
• Dizziness or fainting (more noticeable in older children)
• Breathing irregularities or breath-holding spells

Not every child will have all symptoms, and many signs are subtle, especially in non-verbal children.

🩺 Which Professionals Can Help?
If you suspect dysautonomia, evaluation often involves a multidisciplinary team, which may include:

• Neurologist (especially one familiar with complex neurogenetic conditions)
• Cardiologist (for heart rate and blood pressure regulation)
• Gastroenterologist (for motility and feeding issues)
• Autonomic specialist (when available)
• Geneticist or metabolic specialist
• Pulmonologist (if breathing regulation is affected)

Diagnosis is often clinical, based on symptoms and history, rather than a single definitive test.

🧬 Can Dysautonomia Occur in Children with CYFIP2?
There is currently no published, systematic data defining dysautonomia as a core feature of CYFIP2-related disorders. However, based on clinical experience and what we understand about CYFIP2’s role in the nervous system:

• Dysautonomia is biologically plausible in some individuals with CYFIP2.
• CYFIP2 plays a role in neuronal signaling and brain development, including regions involved in autonomic regulation.
• Children with severe developmental and epileptic encephalopathy (DEE), regardless of the gene, are at increased risk for autonomic instability.

🔬 Is This Limited to Arg87Cys or Could This Be Present in Other Variants?
• Children with Arg87Cys, which is associated with a more severe phenotype, may be at higher risk due to broader neurological involvement.
• That said, dysautonomia might not be exclusive to Arg87Cys.
• Children with other CYFIP2 variants, including those considered less severe, may also experience autonomic symptoms, especially in the presence of seizures or significant neurological involvement.

Severity increases risk, but variant alone does not determine whether dysautonomia can occur.

💡 Why This Matters
Dysautonomia can significantly impact daily life, but recognizing it can change care. Identifying autonomic dysfunction may allow for:

• Symptom-targeted interventions
• Adjustments in medications and feeding plans
• Temperature and environmental strategies
• Better coordination across specialties

Even without a cure, management can make a meaningful difference.

👉 Final Note
If this resonates with your child’s experience, you are not alone. Dysautonomia is often under-recognized in medically complex children, but awareness is the first step toward understanding and support.

As always, the CYFIP2 Network remains committed to listening to family experiences, asking hard questions, and sharing information that helps improve the daily lives of our children.

✨ **Happy New Year from the CYFIP2 Network!** ✨As we step into 2026, we want to begin with gratitude and hope. Every res...
12/30/2025

✨ **Happy New Year from the CYFIP2 Network!** ✨

As we step into 2026, we want to begin with gratitude and hope. Every research connection made this past year brings us closer to a treatment for CYFIP2.

One of the most powerful ways families can support research right now is by starting a fundraiser, whether it’s for a birthday, a milestone, a walk, or simply in honor of your child. Every fundraiser, big or small, directly helps us support research for treatments, like the A*O study for CYFIP2.

We are frequently in contact with researchers who are interested in advancing these studies for CYFIP2 and we hope to continue supporting this momentum. However, we simply cannot provide the requested funding without the support of our community.

Let’s make this a year of action, collaboration, and hope.
Starting a fundraiser is easy and can be done right from our already existing fundraising page. You can share your own story, in your own language, with your own pictures!

➡️https://secure.givelively.org/donate/cyfip2-network-inc/a-cure-for-cyfip2-dee

Thank you to all the families who joined us for yesterday’s virtual meetings. Your time, openness, and willingness to co...
12/16/2025

Thank you to all the families who joined us for yesterday’s virtual meetings. Your time, openness, and willingness to connect really means a lot.

The first meeting was focused on research and treatment development, which was amazing! Thank you for the supportive, thoughtful, and encouraging conversation. It was inspiring to hear your questions, ideas, and hope for what’s ahead. We are looking forward to the drug repurposing effort, especially for Arg87Cys.

The second meeting welcomed two new families who were able to connect and it was great to meet them! If at any point you become interested in getting involved with CYFIP2 research or targeted treatments, we are always just a message away!

When families receive a CYFIP2 diagnosis, one of the challenges is finding the information that exists. Parents spend co...
12/16/2025

When families receive a CYFIP2 diagnosis, one of the challenges is finding the information that exists. Parents spend countless hours searching for answers: reading scientific papers, connecting dots, and trying to understand what the future might hold. We all wish that the medical community already had every answer and could guide us with certainty. But the truth is, CYFIP2 is still being researched, and progress depends on a global research effort powered by families.

Today, we’re proud to share the CYFIP2 Research Roadmap.

This document was created to help families clearly see where CYFIP2 research stands today, what scientists understand, what treatments are being explored, and where the most critical gaps remain. Just as importantly, this roadmap reflects direct collaboration with researchers around the world who are actively studying CYFIP2 and working to translate science into therapies.

The CYFIP2 Research Roadmap is meant to be a living resource: something families can use to learn, to advocate, and get involved with our research — AND something researchers can use to align efforts and accelerate progress. It represents what’s possible when families and scientists work together toward a shared goal: treatments for CYFIP2 and a better future for our children.

We invite you to explore the roadmap and be part of the journey forward. 💙

We extend our sincere gratitude to the researchers who contributed their expertise, time, and insights to this roadmap. Your collaboration and commitment are essential to advancing CYFIP2 research and bringing hope to families.

Matthew Jarpe, Pathfinder Scientific
Dr. Helen Chen, St. Jude's Children's Research Hospital
Dr. Kihoon Han, Korea University
Dr. Kurt Marsden, NCSU
Dr. Anais Begemann, University of Zurich
Dr. Vivek Kumar, The Jackson Laboratory
Dr. Patricia Shigunov, FIOCRUZ
Dr. Isabelle Zaboroski Silva, FIOCRUZ
Dr. Stone Chen, Iowa State University
Dr. Joseph Dougherty, WUSTL
Dr. Alessandro Barbon, University of Brescia
Dr. Jan Procházka, Czech Centre for Phenogenomics..and a special thank you to the many CYFIP2 families worldwide.

Available in English, Portuguese and Italian at: https://www.cyfip2network.org/research-roadmap

This roadmap collects the knowledge, thoughts, ideas, and opinions of key stakeholders in the effort to develop treatments for Developmental Epileptic Encephalopathy 65 (DEE65).

CYFIP2 Family Meeting:For families interested in meeting virtually over Zoom during the week of December 14-20, email su...
12/04/2025

CYFIP2 Family Meeting:

For families interested in meeting virtually over Zoom during the week of December 14-20, email support@cyfip2network.org for a sign up sheet with time/day availability options. We will have translating captions available.

Due to very limited participation, this will be the last CYFIP2 Network hosted family meeting.

RESEARCH ROADMAP INSIDE LOOK:One of the most exciting sections of the CYFIP2 Research Roadmap is all about disease model...
12/02/2025

RESEARCH ROADMAP INSIDE LOOK:

One of the most exciting sections of the CYFIP2 Research Roadmap is all about disease models: the tools scientists rely on to understand how CYFIP2 affects the brain and body.

Inside the roadmap, we break down the development of mouse models, cell lines, and zebrafish, each offering a different window into how CYFIP2 dysfunction works. These models are essential: they help researchers study symptoms and explore potential treatments long before anything reaches a clinical trial.

Right now, most available CYFIP2 models feature the R87C variant, which has been critical for advancing early science. But we also highlight how creating new cell lines with other CYFIP2 variants could offer information we simply don’t have yet.

And here’s where our community comes in.
With enough family participation, a Giving Tuesday gift to the CYFIP2 Network could help us launch our own dedicated biorepository, a centralized, secure resource where donated samples from families could be used to generate new cell lines, aid in drug repurposing efforts and accelerate discoveries across the entire CYFIP2 spectrum.

Every contribution brings us one step closer to the tools researchers need and the answers we hope for. 💙

Consider donating at: https://secure.givelively.org/donate/cyfip2-network-inc/a-cure-for-cyfip2-dee

CYFIP2 Data Collection Program Insights:The CYFIP2 Data Collection Program was launched through RARE-X, a research progr...
12/02/2025

CYFIP2 Data Collection Program Insights:

The CYFIP2 Data Collection Program was launched through RARE-X, a research program of Global Genes. This program is available to families worldwide and allows families to contribute to research from home! There are no required clinic visits and there is no cost to participate.

This program is different from any ongoing natural history studies and you control your data. Register today and join families who are making a difference for CYFIP2.

https://rare-x.org/cyfip2/

RESEARCH ROADMAP INSIDE LOOK:What is "drug repurposing?""Creating an entirely new pharmaceutical drug is an expensive an...
12/02/2025

RESEARCH ROADMAP INSIDE LOOK:

What is "drug repurposing?"

"Creating an entirely new pharmaceutical drug is an expensive and time consuming process and there is little economic incentive to pursue new treatments for ultra-rare diseases. However, finding a new use for an old drug is relatively inexpensive and fast. A little over 300 chemical compounds that act on targets within the brain have been approved for use in humans, and while none of those drugs were approved to treat DEE65, it is possible that one of them has a biological effect that would be beneficial to patients." - CYFIP2 Research Roadmap

"...the next step to determine if compounds would be beneficial to DEE65 patients is to test them in a cell-based assay that would indicate either a restoration of normal Cyfip2 function or removal of the unwanted function..." -CYFIP2 Research Roadmap

At least three labs, both in the United States and internationally, are actively creating these cell-based assays. A complete list of the locations of CYFIP2 disease models to date is included in the roadmap!

A gift to the CYFIP2 Network today helps us keep this important work going. If able, please consider donating to help us move these studies forward for CYFIP2 children. Thank you.

https://secure.givelively.org/donate/cyfip2-network-inc/a-cure-for-cyfip2-dee

Quote: "When I am working on a cell line in the lab, I remind myself that this is a cell from a patient who has a family. It is important to stop and think about that sometimes."
– Dr. Isabelle Zaboroski Silva

RESEARCH ROADMAP INSIDE LOOK:How do scientists become interested in studying CYFIP2?We asked the leading CYFIP2 research...
12/02/2025

RESEARCH ROADMAP INSIDE LOOK:

How do scientists become interested in studying CYFIP2?
We asked the leading CYFIP2 researchers what sparked their interest!

Their responses came from very different areas of study but all led to significant contributions:
1. A study to find the reason why two related strains of mice respond differently to co***ne,
2. Parents of a child with epileptic encephalopathy looking for answers in laboratory science,
3. A search for genes that control the response of fish larvae to loud noises,
4. A molecular dissection of the components of a protein complex that controls cellular movement and shape,
5. An investigation into the cause of Fragile X syndrome.

✨ Together, these unexpected paths met to understand CYFIP2 and improve the lives of the children and families living with CYFIP2 conditions.
This is the power of science and community.

Its Giving Tuesday and we're kicking it off now for CYFIP2!Today, we are coming together to fuel hope, accelerate resear...
12/02/2025

Its Giving Tuesday and we're kicking it off now for CYFIP2!

Today, we are coming together to fuel hope, accelerate research, and stand behind every child and family affected by CYFIP2.

As a thank-you to donors who give today, we’re gifting CYFIP2-engraved Christmas ornaments, a small symbol of the light you bring to our community.✨🎄

And all day long, we’ll be sharing sneak peeks of our CYFIP2 Research Roadmap: the collaborative, global effort charting the path toward understanding, treatments, and impact. Your support is what makes this work possible.

💙 Join us today. Give hope. Spark progress. Be part of the story.
Donate → https://secure.givelively.org/donate/cyfip2-network-inc/a-cure-for-cyfip2-dee

Thank you for showing up for CYFIP2!

The CYFIP2 Network is a group of parents, friends, researchers and supporters all working to find a cure for CYFIP2 Developmental and Epileptic Encephalopathy (also ca...

12/02/2025

📣 Big News for Rare Kids!

The House of Representatives just passed the Give Kids a Chance Act! It now heads to the Senate for approval and this is a BIG deal for families affected by rare pediatric diseases, including CYFIP2-related disorders.

What this bill does:

•Re-authorizes the Rare Pediatric Disease Priority Review Voucher (PRV) Program through 2029.

•The PRV gives companies a major incentive to develop treatments for rare childhood conditions by offering a fast-track FDA review (or a voucher they can sell to fund more research).

•Strengthens requirements for completing pediatric studies so kids aren’t left behind in drug development.

Why it matters for CYFIP2:

Because CYFIP2 is ultra-rare, companies often hesitate to invest. Extending the PRV program helps make developing treatments (including repurposed drugs or future targeted therapies) financially realistic. Every bit of incentive helps bring CYFIP2 children closer to the therapies they need.

Next step: The Senate must pass it. Please stay engaged and keep raising your voice for CYFIP2 kids 💙

Address

450 Carthage Street, PO BOX 333
Cameron, NC
28326

Alerts

Be the first to know and let us send you an email when Cyfip2 Network posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Cyfip2 Network:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram